Literature DB >> 10680813

Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia.

L Parnetti1, G P Reboldi, V Gallai.   

Abstract

Increased amounts of CSF pyruvate and lactate were found in patients with AD and patients with vascular dementia (VaD). In the AD group, CSF pyruvate values did not show any overlap with those obtained in controls; within the VaD group, the highest values were observed in possible VaD cases. A significant correlation between the severity of dementia and these biochemical parameters was also observed in both AD and possible VaD. The similarities of CSF pyruvate patterns observed in AD and possible VaD patients implicate a neurodegenerative component in this VaD subgroup.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10680813     DOI: 10.1212/wnl.54.3.735

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Proteomic identification of specifically carbonylated brain proteins in APP(NLh)/APP(NLh) × PS-1(P264L)/PS-1(P264L) human double mutant knock-in mice model of Alzheimer disease as a function of age.

Authors:  Rukhsana Sultana; Renã A S Robinson; Fabio Di Domenico; Hafiz Mohmmad Abdul; Daret K St Clair; William R Markesbery; Jian Cai; William M Pierce; D Allan Butterfield
Journal:  J Proteomics       Date:  2011-06-25       Impact factor: 4.044

Review 2.  Why pleiotropic interventions are needed for Alzheimer's disease.

Authors:  Sally A Frautschy; Greg M Cole
Journal:  Mol Neurobiol       Date:  2010-05-02       Impact factor: 5.590

3.  Cerebrospinal fluid lactate levels and brain [18F]FDG PET hypometabolism within the default mode network in Alzheimer's disease.

Authors:  Claudio Liguori; Agostino Chiaravalloti; Giuseppe Sancesario; Alessandro Stefani; Giulia Maria Sancesario; Nicola Biagio Mercuri; Orazio Schillaci; Mariangela Pierantozzi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-05-25       Impact factor: 9.236

Review 4.  Redox signaling and Alzheimer's disease: from pathomechanism insights to biomarker discovery and therapy strategy.

Authors:  Yuan-Yuan Chen; Min-Chang Wang; Yan-Ni Wang; He-He Hu; Qing-Quan Liu; Hai-Jing Liu; Ying-Yong Zhao
Journal:  Biomark Res       Date:  2020-09-11

5.  Cerebrospinal fluid lactate levels along the Alzheimer's disease continuum and associations with blood-brain barrier integrity, age, cognition, and biomarkers.

Authors:  Paul Theo Zebhauser; Achim Berthele; Oliver Goldhardt; Janine Diehl-Schmid; Josef Priller; Marion Ortner; Timo Grimmer
Journal:  Alzheimers Res Ther       Date:  2022-04-26       Impact factor: 8.823

6.  Effects of Combining Biofactors on Bioenergetic Parameters, Aβ Levels and Survival in Alzheimer Model Organisms.

Authors:  Lukas Babylon; Fabian Schmitt; Yannik Franke; Tim Hubert; Gunter P Eckert
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.